Phase 1 Study of AZD9833 Alone or in Combination in Women with Advanced Breast Cancer
D8530C00001
Phase 1 other active
Quick answer
Phase 1 Study of AZD9833 Alone or in Combination in Women with Advanced Breast Cancer for "Estrogen Receptor Positive HER2 Negative Advanced Breast Cancer" is a Phase 1 program (other) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- "Estrogen Receptor Positive HER2 Negative Advanced Breast Cancer"
- Phase
- Phase 1
- Modality
- other
- Status
- active